Research Compound · Tirzepatide

Tirzepatide Research Compound —
Independently Verified.

Tirzepatide — investigational dual GIP/GLP-1 receptor co-agonist. The first dual incretin research compound to achieve FDA approval (Mounjaro/Zepbound). Studied for metabolic pathway research. 30mg lyophilized, HPLC verified.

≥98% HPLC PurityMass Spec VerifiedLyophilized · 30mgCOA IncludedUSA Operations

Order Tirzepatide — $175.00 Read the research guide

$175.00

per 30mg vial

In Stock

Order Tirzepatide

COA included with every order
For laboratory research use only

HPLC Verified≥98% purity confirmed per lot

COA IncludedLot-specific certificate ships with order

Mass Spec IDMolecular identity confirmed per batch

USA OperationsVerified sourcing. Documented chain.

About This Compound

What Is Tirzepatide?

Tirzepatide is a 39-amino-acid synthetic peptide that acts as a dual agonist at both the glucose-dependent insulinotropic polypeptide (GIP) receptor and the glucagon-like peptide-1 (GLP-1) receptor. Developed by Eli Lilly, it received FDA approval as Mounjaro (type 2 diabetes) and Zepbound (obesity) — making it one of the few research peptides with a corresponding FDA-approved pharmaceutical counterpart.

In research settings, Tirzepatide is studied as a pharmacological tool for investigating dual incretin receptor pharmacology, the relative contributions of GIP vs GLP-1 agonism to metabolic outcomes, and adipose tissue regulation in preclinical models.

For a full breakdown of the research literature, read our Tirzepatide research guide →

// compound profile

CompoundTirzepatide

ClassDual GIP/GLP-1 receptor agonist

Amino Acids39

StatusFDA-approved drug (Mounjaro/Zepbound)

FormLyophilized powder

Size30mg per vial

Purity≥98% HPLC

What Sets Us Apart

We Verify Before We Ship.

CoreVionRX doesn’t manufacture peptides. What we do — rigorously — is verify every batch before it reaches our catalog.

≥98%

Purity by Reversed-Phase HPLC

HPLC separates the compound from any impurities and measures the exact purity percentage. The chromatogram is documented on your COA.

MS/MS

Mass Spectrometry Identity Check

Electrospray ionization mass spectrometry verifies the molecular weight matches the compound specification. Confirms you’re getting the actual compound.

Lot #

Lot-Specific Certificate of Analysis

Your COA is tied to your specific production lot — not a generic document. This is not standard practice in this market. We made it one anyway.

100%

Documented Before Listing

No compound reaches our catalog without clearing our verification process first. If documentation isn’t available for a batch, that batch doesn’t ship.

Technical Specifications

Full Product Data

Everything you need to evaluate this compound for your research protocol.

Specification	Value
Compound	Tirzepatide
Class	Dual GIP/GLP-1 receptor co-agonist
Amino Acids	39
Drug Status	FDA-approved pharmaceutical (Mounjaro/Zepbound) — research compound sold separately
Form	Lyophilized powder
Vial Size	30mg per vial
Purity	≥98% by reversed-phase HPLC
Identity	Confirmed by electrospray ionization mass spectrometry
Storage (lyophilized)	−20°C, protected from light and moisture
Storage (reconstituted)	2–8°C, away from light
Documentation	Lot-specific COA with HPLC chromatogram — included with every order

Preclinical Research

What Researchers Study Tirzepatide For

All published research is preclinical — cell cultures and animal models. No human clinical trial data exists for Tirzepatide. Here’s where the science currently stands.

Dual Incretin Receptor Research

Tirzepatide is studied as a pharmacological tool for examining simultaneous GIP and GLP-1 receptor activation. Research investigates the relative contribution of each receptor subtype to insulin secretion, glucagon suppression, and gastric emptying.

Frías JP. et al. (2021) N Engl J Med 385(6):503-15

Metabolic Regulation Studies

Preclinical and clinical research has examined Tirzepatide’s effects on insulin secretion kinetics, hepatic glucose production, and glucagon regulation. The dual agonist mechanism produces effects distinct from either GIP or GLP-1 agonism alone.

Samms RJ. et al. (2021) Cell Metab 33(6):1123-35

Adipose Tissue Research

Research examines Tirzepatide’s effects on adipose tissue biology — including lipolysis, adipogenesis, and brown adipose tissue activation — to understand how dual GIP/GLP-1 agonism produces metabolic effects beyond glucose regulation alone.

Thomas MK. et al. (2021) J Clin Endocrinol Metab 106(2):388-96

Why CoreVionRX

Documentation Is the Product.

Most peptide vendors claim purity. We document it. Every compound ships with independent lab verification — not because regulations require it, but because you deserve to know exactly what you’re working with.

Independent HPLC Testing

Every batch runs through reversed-phase HPLC before we list it. The chromatogram appears on your COA. Verify the peak profile yourself.

Lot-Specific Documentation

Your COA is tied to your production lot — not a template document. “COA available upon request” is not how we operate.

Transparent About What We Are

We source and verify. We are not a synthesis lab. That honesty is deliberate — it’s the only way to build a brand worth buying from twice.

Lyophilized for Stability

Ships as lyophilized powder — stable at −20°C for 24+ months. Full integrity maintained until you’re ready to reconstitute.

Common Questions

Straight Answers.

What is Tirzepatide and how does it differ from GLP-1 agonists?

Tirzepatide is a 39-amino-acid dual agonist at both the GIP receptor and GLP-1 receptor. Most well-known GLP-1 agonists (semaglutide, liraglutide) act only at GLP-1R. Tirzepatide’s additional GIP receptor activity is the subject of active research to understand the differential contribution of each pathway to metabolic outcomes.

Is Tirzepatide the same as Mounjaro or Zepbound?

Tirzepatide is the active compound in Mounjaro (FDA-approved for T2D) and Zepbound (FDA-approved for obesity). The research compound sold by CoreVionRX is Tirzepatide as a raw research peptide — a separate form from the pharmaceutical drug. It is sold strictly for laboratory research use, not for human administration.

What research areas use Tirzepatide?

Research focuses on dual GIP/GLP-1 receptor pharmacology, comparative incretin biology, insulin secretion kinetics, hepatic glucose regulation, and adipose tissue biology. The availability of clinical data makes Tirzepatide particularly interesting for translational research.

How do I reconstitute Tirzepatide for research?

Reconstitute with bacteriostatic water. Given the 30mg vial, plan your target concentration based on your protocol volume needs. Inject water slowly down the vial wall, swirl gently. Use our reconstitution calculator for exact volumes.

How should Tirzepatide be stored?

Store lyophilized at −20°C, protected from light and moisture. After reconstitution, store at 2–8°C away from light. The 30mg format is suitable for lab settings requiring larger volumes across multiple experiments.

Continue Your Research

Related Resources

Ready to Order Tirzepatide?

In stock. COA included. HPLC + mass spec verified. Ships with full documentation.

Order Tirzepatide — $175.00 Browse All Compounds

≥98% HPLC PurityLot-Specific COAMass Spec VerifiedUSA Operations

For laboratory research use only. Not for human or animal consumption.
CoreVionRX supplies research compounds to qualified laboratories and research institutions.

Tirzepatide Research Compound —Independently Verified.